Kunxian Capsule Extract Inhibits Angiogenesis in Zebrafish Embryos via PI3K/AKT-MAPK-VEGF Pathway.
10.1007/s11655-022-3625-5
- Author:
Rui-Jiao MA
1
;
Maharajan KANNAN
1
;
Qing XIA
1
;
Shan-Shan ZHANG
1
;
Peng-Fei TU
2
;
Ke-Chun LIU
1
;
Yun ZHANG
3
Author Information
1. Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250103, China.
2. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
3. Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250103, China. xiaohan_0818@163.com.
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
angiogenesis;
osteoporosis;
rheumatoid arthritis;
synovial inflammation
- MeSH:
Animals;
Fibroblast Growth Factor 2;
Human Umbilical Vein Endothelial Cells;
Mitogen-Activated Protein Kinases/metabolism*;
Phosphatidylinositol 3-Kinase;
Phosphatidylinositol 3-Kinases/metabolism*;
Proto-Oncogene Proteins c-akt/metabolism*;
Vascular Endothelial Growth Factor A/metabolism*;
Zebrafish
- From:
Chinese journal of integrative medicine
2023;29(2):137-145
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To investigate the anti-angiogenic activity of Kunxian Capsule (KX) extract and explore the underlying molecular mechanism using zebrafish.
METHODS:The KX extract was prepared with 5.0 g in 100 mL of 40% methanol followed by ultrasonication and freeze drying. Freeze dried KX extract of 10.00 mg was used as test stock solution. Triptolide and icariin, the key bioactive compounds of KX were analyzed using ultra-high performance liquid chromatography. The transgenic zebrafish Tg(flk1:GFP) embryos were dechorionated at 20-h post fertilization (hpf) and treated with PTK 787, and 3.5, 7, 14 and 21 µg/mL of KX extract, respectively. After 24-h post exposure (hpe), mortality and malformation (%), intersegmental vessels (ISV) formation, and mRNA expression level of angiogenic pathway genes including phosphoinositide 3-kinase (PI3K), protein kinase B (AKT), extracellular signal-regulated kinases (ERKs), mitogen-activated protein kinase (MAPK), vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF-2) were determined. Further, the embryos at 72 hpf were treated with KX extract to observe the development of sub-intestinal vein (SIV) after 24 hpe.
RESULTS:The chromatographic analysis of test stock solution of KX extract showed that triptolide and icariin was found as 0.089 mg/g and 48.74 mg/g, respectively, which met the requirements of the national drug standards. In zebrafish larvae experiment, KX extract significantly inhibited the ISV (P<0.01) and SIV formation (P<0.05). Besides, the mRNA expression analysis showed that KX extract could significantly suppress the expressions of PI3K and AKT, thereby inhibiting the mRNA levels of ERKs and MAPK. Moreover, the downstream signaling cascade affected the expression of VEGF and its receptors (VEGFR and VEGFR-2). FGF-2, a strong angiogenic factor, was also down-regulated by KX treatment in zebrafish larvae.
CONCLUSION:KX extract exhibited anti-angiogenic effects in zebrafish embryos by regulating PI3K/AKT-MAPK-VEGF pathway and showed promising potential for RA treatment.
